Coût de prise en charge des cancers de la vulve et du vagin en France (notice n° 272351)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03535cam a2200325 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112081616.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rémy, Vanessa |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Coût de prise en charge des cancers de la vulve et du vagin en France |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2010.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 88 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Objectif : L’objectif de cette étude était d’estimer le coût annuel associé à la prise en charge des cancers et lésions de la vulve (VIN) et du vagin (VaIN) en France du point de vue de l’Assurance Maladie. Matériel et méthodes : Cette étude se base sur les données du Programme de Médicalisation des Systèmes d’Information (PMSI) en 2006 regroupant les données nationales des établissements hospitaliers publics et privés. Les coûts ont été estimés par les tarifs officiels des groupes homogènes de séjours. Une analyse additionnelle a permis d’estimer les coûts ambulatoires et les indemnités journalières pour les cancers de la vulve et du vagin. Résultats : En France, 1 237 patientes ont été hospitalisées pour un cancer de la vulve et 728 pour un cancer du vagin en 2006. Le coût total annuel de la prise en charge des cancers de la vulve et du vagin s’élève respectivement à 9,3 et 6,7 millions d’euros. Le coût lié aux hospitalisations pour VIN et VaIN s’élève à 1,3 millions d’euros. Conclusion : Le coût global annuel de la prise en charge des lésions et cancers de la vulve et du vagin est proche de 17,4 millions d’euros pour l’Assurance Maladie, cette estimation étant probablement sous-estimée du fait de la non prise en compte des coûts associés à la prise en charge ambulatoire des lésions. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Costs of management of vulvar and vaginal cancers in France Objective : The objective of this study was to assess the annual cost associated with the management of vulvar and vaginal cancers and lesions from the health care payer perspective in France. Material and methods : This study is based on data extracted from the French national hospital database (PMSI) in 2006, which collects data from all public and private hospitals in France. Hospital costs were based on official tariffs for diagnosis-related groups. A complementary analysis allowed us to estimate outpatient and daily allowance costs for vulvar and vaginal cancers. Results : In France, 1237 patients were hospitalised for vulvar cancer and 728 for vaginal cancer in 2006. The total annual cost for the management of vulvar and vaginal cancers reaches 9.3 and 6.7 million Euros, respectively. The hospitalisation cost for vulvar and vaginal lesions is estimated at 1.3 million Euros. Conclusion : The overall annual cost for the management of vulvar and vaginal cancers and lesions is approximately 17.4 million Euros for the French health care payer. Since outpatient management cost for vulvar and vaginal lesions is not taken into account, the overall cost is probably underestimated. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vulve |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | PMSI |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vagin |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | coût |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vulva |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | PMSI |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vagina |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cost |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mathevet, Patrice |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Largeron, Nathalie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vainchtock, Alexandre |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Journal d'économie médicale | Volume 28 | 1 | 2010-01-01 | p. 31-45 | 0294-0736 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-journal-de-gestion-et-d-economie-medicales1-2010-1-page-31?lang=fr">https://shs.cairn.info/revue-journal-de-gestion-et-d-economie-medicales1-2010-1-page-31?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux